Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does VALACYCLOVIR Cause Hepatic function abnormal? 25 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 25 reports of Hepatic function abnormal have been filed in association with VALACYCLOVIR (Valacyclovir Hydrochloride). This represents 0.2% of all adverse event reports for VALACYCLOVIR.

25
Reports of Hepatic function abnormal with VALACYCLOVIR
0.2%
of all VALACYCLOVIR reports
0
Deaths
11
Hospitalizations

How Dangerous Is Hepatic function abnormal From VALACYCLOVIR?

Of the 25 reports, 11 (44.0%) required hospitalization, and 2 (8.0%) were considered life-threatening.

Is Hepatic function abnormal Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for VALACYCLOVIR. However, 25 reports have been filed with the FAERS database.

What Other Side Effects Does VALACYCLOVIR Cause?

Acute kidney injury (978) Drug ineffective (894) Off label use (593) Pyrexia (551) Drug reaction with eosinophilia and systemic symptoms (496) Confusional state (456) Rash (423) Nausea (415) Neurotoxicity (404) Altered state of consciousness (395)

What Other Drugs Cause Hepatic function abnormal?

NIVOLUMAB (1,131) PEMBROLIZUMAB (1,079) METHOTREXATE (1,054) CABOZANTINIB S-MALATE (912) CYCLOPHOSPHAMIDE (824) BEVACIZUMAB (769) PACLITAXEL (603) LENVATINIB (528) ATORVASTATIN (520) CYCLOSPORINE (508)

Which VALACYCLOVIR Alternatives Have Lower Hepatic function abnormal Risk?

VALACYCLOVIR vs VALBENAZINE VALACYCLOVIR vs VALBENAZINE DITOSYLATE VALACYCLOVIR vs VALDECOXIB VALACYCLOVIR vs VALERIAN VALACYCLOVIR vs VALGANCICLOVIR

Related Pages

VALACYCLOVIR Full Profile All Hepatic function abnormal Reports All Drugs Causing Hepatic function abnormal VALACYCLOVIR Demographics